• Published on: Apr 04, 2020
  • 2 minute read
  • By: Dr Rajan Choudhary

THE CHALLENGES FACED IN MAKING A VACCINE FOR COVID-19 — Part 2

  • WhatsApp share link icon
  • copy & share link icon
  • twitter share link icon
  • facebook share link icon

Previously we’ve seen the difficulties researches face in trying to make a vaccine. But even if we make a vaccine, that’s just half the battle. Viruses are unique because they can mutate, and they can mutate to astonishing degrees. In humans mutations to tiny parts of our DNA can cause severe diseases or even death. In viruses mutations can change their structure, making them more infective and giving them a new coat. It gives them a survival advantage, the ability to evade our immune system and make our vaccines ineffective. This is why we need a new flu vaccine every year.

If it takes months to a year to develop a vaccine, it will be based off the virus found in December 2019. By this time the virus may have spread and mutated to such a degree that it is not effective. This does not mean all the effort was for nothing. Going through the steps and understanding the issues faced with making a COVID-19 vaccine can make the process quicker for subsequent vaccines against its mutated versions.

https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away So Long to Develop a Vaccine

FAILURES FROM THE PAST

These issues were faced during the Ebola and Zika virus epidemics, and many large companies are understandably hesitant to develop vaccines for COVID-19. Ebola first broke out in 2014, and it was only in December 2019 that the first vaccine was approved for use by the European Commission and the United States. This is despite multiple large institutes in Canada and the UK working together to develop it.

13 different Ebola vaccine candidates had been identified soon after the outbreak, but none had been tested on humans. Unfortunately this is the most expensive part of development, and the area biopharmecuticals stand to loose the most money. Return on investments is also low, since epidemics usually take place in poorer countries, and the potential customers are unable to pay the high prices for these brand new treatments. It is an unfortunate realisation that research into medicines is driven by rich countries, for diseases that affect the rich.

https://newint.org/features/web-exclusive/2016/06/16/why-did-the-market-fail-to-produce-an-ebola-vaccine Ebola 

WHERE ARE WE NOW?

This is all well and good, but what does it mean for COVID-19? We know we cannot rush a vaccine, because a poorly designed vaccine with unknown side effects can cause more harm than good, especially if given to children or the elderly. Currently the WHO are tracking 31 different attempts at making a COVID-19 vaccine, using different methods as discussed before. All of these are currently in the pre-clinical stage, focusing on isolating parts of the virus and creating a target the body will recognise and react to.

Researchers at the University of Queensland were one of the first to start using the genetic code of COVID-19, released openly by Chinese researchers. They have developed a test vaccine within 6 weeks using state-of-the-art genetic techniques, used for the first time. If animal models prove successful then human testing might begin within 6 months. In the pharmaceutical industry advancements this quick are almost unheard of.

Additionally over 293 clinical trials are taking place in China using existing drugs on the market. The advantage is we already know these drugs are safe to use in humans, but we are trying to work out if they will work against COVID-19. Some scientists are also looking at medications that were initially developed against SARS and MERS, but never completed because these outbreaks died down and the medication was no longer required.

https://www.aljazeera.com/news/2020/03/china-recovered-develop-effective-covid-19-treatments-200302082850237.html COVID-19 treatments

https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf?ua=1 WHO news

https://www.theverge.com/2020/2/28/21156385/covid-coronavirus-vaccine-treatment-moderna-remdesivir-research COVID-19 treatment

Its not all doom and gloom. Challenges drive innovation, and we are already benefitting from this. New forms of genetic sequencing, new methods for extracting viral proteins, new techniques in creating a vaccine. These innovations are already benefitting us on the drive to create an effective vaccine for COVID-19, and they will benefit us in the future when the next pandemic hits.

Dr Rajan Choudhary, Product Manager Second Medic UK

www.secondmedic.com

Read Blog
Desk Plants

Only Health-Based Rewards: Why Wellness-Focused Incentives Drive Healthier Workplaces

Corporate rewards have traditionally focused on monetary incentives, gift cards or generic perks. However, organisations are increasingly realising that such rewards offer only short-lived motivation. Only health-based rewards, such as massages, gym bags and fitness trackers, represent a more effective approach to corporate wellness by reinforcing healthy behaviours that deliver long-term benefits.

In India, where lifestyle diseases are rising rapidly among working professionals, aligning rewards with health outcomes is no longer optional.

 

What Are Health-Based Rewards?

Health-based rewards are incentives designed specifically to improve or support employee wellbeing.

They focus on:

  • physical health

  • mental wellbeing

  • preventive care

  • recovery and stress relief

Unlike cash incentives, they encourage repeated healthy actions.

 

Why Traditional Rewards Fall Short

Cash rewards and generic gifts:

  • provide temporary satisfaction

  • do not influence daily habits

  • fail to support long-term wellbeing

Behavioural studies show that incentives disconnected from health goals have limited preventive impact.

 

The Case for Only Health-Based Rewards

Health-based rewards directly reinforce behaviours such as:

  • regular physical activity

  • stress management

  • recovery and self-care

  • preventive health participation

WHO workplace health guidelines emphasise incentives that promote sustained behaviour change.

 

Types of Effective Health-Based Rewards

Massages and Recovery Therapies

Massage therapy:

  • reduces muscle tension

  • lowers stress hormones

  • improves circulation

Monthly or quarterly massage rewards support physical and mental recovery.

 

Gym Bags and Fitness Gear

Practical fitness accessories:

  • encourage regular workouts

  • reduce barriers to exercise

  • promote active lifestyles

Visible gear reinforces identity as a health-conscious individual.

 

Fitness Trackers

Fitness trackers:

  • track steps, activity and sleep

  • create accountability

  • encourage daily movement

Data-driven feedback increases participation and motivation.

 

Psychological Impact of Health-Based Rewards

Health rewards create:

  • intrinsic motivation

  • positive habit reinforcement

  • long-term lifestyle shifts

Unlike cash, they associate rewards with self-care rather than consumption.

 

Impact on Employee Health Outcomes

Regular participation in wellness incentives leads to:

  • improved physical activity levels

  • reduced stress

  • better sleep patterns

ICMR data links activity-based interventions with lower lifestyle disease risk.

 

Benefits for Employers

Reduced Healthcare Costs

Preventive health rewards reduce chronic disease burden over time.

Improved Productivity

Healthy employees demonstrate:

  • better focus

  • fewer sick days

  • higher energy levels

Stronger Wellness Culture

Health-first rewards signal genuine organisational commitment.

EY-FICCI reports show preventive wellness programs deliver measurable ROI within 12–18 months.

 

Why Health-Based Rewards Work Better in India

Indian workplaces face:

  • long working hours

  • sedentary routines

  • high stress levels

Health rewards directly address these risks rather than ignoring them.

 

Aligning Rewards With Preventive Healthcare

Health-based rewards complement:

  • health screenings

  • fitness challenges

  • mental wellbeing programs

This integrated approach strengthens outcomes.

 

Avoiding Pitfalls in Reward Design

Effective programs:

  • avoid one-size-fits-all rewards

  • offer choice within health categories

  • ensure inclusivity

Poorly designed incentives reduce engagement.

 

Measuring Success of Health-Based Rewards

Success indicators include:

  • participation rates

  • health screening uptake

  • employee feedback

  • reduced absenteeism

Data-driven evaluation improves program effectiveness.

 

Long-Term Behaviour Change

Sustained wellness improvement requires:

  • consistency

  • reinforcement

  • meaningful incentives

Health-based rewards support gradual but lasting change.

 

Role of Leadership Support

Leadership participation:

  • increases credibility

  • boosts engagement

  • normalises wellness culture

When leaders embrace health rewards, employees follow.

 

Health-Based Rewards and Mental Wellbeing

Rewards such as massages and fitness trackers:

  • reduce burnout

  • improve mood

  • enhance resilience

Creating a Preventive Wellness Ecosystem

Only health-based rewards work best when combined with:

  • education

  • screenings

  • access to care

WHO emphasises integrated wellness ecosystems for maximum impact.

 

Conclusion

Only health-based rewards represent a strategic shift from short-term perks to long-term wellbeing investments. Incentives such as massages, gym bags and fitness trackers actively promote healthy habits, reduce lifestyle disease risk and strengthen workplace wellness culture. By aligning rewards with preventive health goals, organisations create meaningful engagement, healthier employees and sustainable productivity gains. Health-focused incentives are not just rewards—they are tools for lasting wellbeing.

 

References

  • Indian Council of Medical Research (ICMR) – Lifestyle Disease and Workplace Health Reports
  • World Health Organization (WHO) – Workplace Health Promotion and Incentives
  • National Family Health Survey (NFHS-5) – Adult Lifestyle Risk Factors
  • Lancet – Behavioural Incentives and Preventive Health Studies
  • NITI Aayog – Preventive Healthcare and Workforce Wellbeing
  • EY-FICCI – Corporate Wellness and Productivity Reports
  • Statista – Employee Wellness Incentive Trends

See all

Live Doctor consultation
Live Doctor Chat

Download Our App & Get Consultation from anywhere.

App Download
call icon for mobile number calling and whatsapp at secondmedic